Hält derzeit eine Position bei Mersana Therapeutics Inc
Position | Company | Period |
---|---|---|
Chief Science and Technology Officer | Mersana Therapeutics Inc | 1. August 2019 - |
Chief Scientific Officer | Mersana Therapeutics Inc | 1. Februar 2008 - 1. August 2019 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-01-18 | 2023-01-17 |
Mersana Therapeutics Inc
(MRSN)
|
V Verkauf |
6.233
-3.3%
5,7435.777 USD |
6.233 -3.3% | 5,74 | 35.777 USD | |
2022-01-19 | 2022-01-18 |
Mersana Therapeutics Inc
(MRSN)
|
V Verkauf |
4.741
-3.5%
5,9228.067 USD |
4.741 -3.5% | 5,92 | 28.067 USD | |
2021-07-19 | 2021-07-19 |
Mersana Therapeutics Inc
(MRSN)
|
V Verkauf |
8.496
-10.2%
12,02102.122 USD |
8.496 -10.2% | 12,02 | 102.122 USD | |
2021-07-19 | 2021-07-16 |
Mersana Therapeutics Inc
(MRSN)
|
V Verkauf |
7.775
-8.5%
12,4796.954 USD |
7.775 -8.5% | 12,47 | 96.954 USD | |
2021-06-23 | 2021-06-21 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.218
-6.6%
13,7830.564 USD |
2.218 -6.6% | 13,78 | 30.564 USD | |
2021-06-23 | 2021-06-21 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2
-0.0%
13,7828 USD |
2 -0.0% | 13,78 | 28 USD | |
2021-05-24 | 2021-05-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-6.6%
14,1031.401 USD |
2.227 -6.6% | 14,10 | 31.401 USD | |
2021-05-24 | 2021-05-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.875
-5.6%
14,1026.438 USD |
1.875 -5.6% | 14,10 | 26.438 USD | |
2021-04-22 | 2021-04-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-6.6%
15,9135.432 USD |
2.227 -6.6% | 15,91 | 35.432 USD | |
2021-04-22 | 2021-04-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.875
-5.6%
15,9129.831 USD |
1.875 -5.6% | 15,91 | 29.831 USD | |
2021-03-24 | 2021-03-22 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-6.6%
17,5038.973 USD |
2.227 -6.6% | 17,50 | 38.973 USD | |
2021-03-24 | 2021-03-22 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.875
-5.6%
17,5032.813 USD |
1.875 -5.6% | 17,50 | 32.813 USD | |
2021-03-24 | 2021-03-22 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-6.6%
17,5038.973 USD |
2.227 -6.6% | 17,50 | 38.973 USD | |
2021-03-24 | 2021-03-22 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.874
-5.6%
17,5032.795 USD |
1.874 -5.6% | 17,50 | 32.795 USD | |
2021-02-24 | 2021-02-22 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-6.6%
20,0144.562 USD |
2.227 -6.6% | 20,01 | 44.562 USD | |
2021-02-24 | 2021-02-22 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.875
-5.6%
20,0137.519 USD |
1.875 -5.6% | 20,01 | 37.519 USD | |
2021-02-24 | 2021-02-22 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-6.6%
20,0144.562 USD |
2.227 -6.6% | 20,01 | 44.562 USD | |
2021-02-24 | 2021-02-22 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.874
-5.6%
20,0137.499 USD |
1.874 -5.6% | 20,01 | 37.499 USD | |
2021-01-22 | 2021-01-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-6.6%
21,5447.970 USD |
2.227 -6.6% | 21,54 | 47.970 USD | |
2021-01-22 | 2021-01-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.875
-5.6%
21,5440.388 USD |
1.875 -5.6% | 21,54 | 40.388 USD | |
2021-01-22 | 2021-01-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-6.6%
21,5447.970 USD |
2.227 -6.6% | 21,54 | 47.970 USD | |
2021-01-22 | 2021-01-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.874
-5.6%
21,5440.366 USD |
1.874 -5.6% | 21,54 | 40.366 USD | |
2020-12-22 | 2020-12-21 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-100.0%
25,6057.011 USD |
2.227 -100.0% | 25,60 | 57.011 USD | |
2020-12-22 | 2020-12-21 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.875
-100.0%
25,6048.000 USD |
1.875 -100.0% | 25,60 | 48.000 USD | |
2020-12-22 | 2020-12-21 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-100.0%
25,5956.989 USD |
2.227 -100.0% | 25,59 | 56.989 USD | |
2020-12-22 | 2020-12-21 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.874
-100.0%
25,5947.956 USD |
1.874 -100.0% | 25,59 | 47.956 USD | |
2020-11-24 | 2020-11-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-100.0%
23,0451.310 USD |
2.227 -100.0% | 23,04 | 51.310 USD | |
2020-11-24 | 2020-11-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.875
-100.0%
23,0443.200 USD |
1.875 -100.0% | 23,04 | 43.200 USD | |
2020-11-24 | 2020-11-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-100.0%
23,0651.355 USD |
2.227 -100.0% | 23,06 | 51.355 USD | |
2020-11-24 | 2020-11-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.874
-100.0%
23,0643.214 USD |
1.874 -100.0% | 23,06 | 43.214 USD | |
2020-10-22 | 2020-10-21 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-11.7%
17,5038.973 USD |
2.227 -11.7% | 17,50 | 38.973 USD | |
2020-10-22 | 2020-10-21 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.874
-10.0%
17,5032.795 USD |
1.874 -10.0% | 17,50 | 32.795 USD | |
2020-10-22 | 2020-10-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
2.227
-100.0%
16,7437.280 USD |
2.227 -100.0% | 16,74 | 37.280 USD | |
2020-10-22 | 2020-10-20 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
1.875
-100.0%
16,7431.388 USD |
1.875 -100.0% | 16,74 | 31.388 USD | |
2020-09-23 | 2020-09-21 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
12.411
-100.0%
20,66256.379 USD |
12.411 -100.0% | 20,66 | 256.379 USD | |
2020-09-23 | 2020-09-21 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
4.454
-26.4%
20,6692.008 USD |
4.454 -26.4% | 20,66 | 92.008 USD | |
2020-09-23 | 2020-09-21 |
Mersana Therapeutics Inc
(MRSN)
|
GV Geplanter Verkauf |
3.749
-23.2%
20,6677.445 USD |
3.749 -23.2% | 20,66 | 77.445 USD |